Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis

An estimated 19 million people are infected with rifampicin-resistant/multidrug-resistant strains of tuberculosis worldwide. There is little done to prevent these individuals from becoming sick with RR/MDR-TB, a disease that is associated with high rates of morbidity, mortality, and suffering. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Reuter, Anja, Furin, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222449/
https://www.ncbi.nlm.nih.gov/pubmed/37242398
http://dx.doi.org/10.3390/pathogens12050728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222449/
https://www.ncbi.nlm.nih.gov/pubmed/37242398
http://dx.doi.org/10.3390/pathogens12050728

Ejemplares similares